Cantor Fitzgerald Starts AngioDynamics (ANGO) at Buy
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Cantor Fitzgerald initiated coverage on AngioDynamics (NASDAQ: ANGO) with a Buy rating and a price target of $19.00.
Shares of AngioDynamics closed at $15.52 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Credit Suisse Starts Incyte (INCY) at Outperform, Says Jakafi Growth & Pipeline Expansion + Scarity Drives Bullish View
- Morgan Stanley Starts Liberty Global (LBTYA) at Equalweight
- UPDATE: Seaport Global Securities Upgrades Columbus McKinnon (CMCO) to Buy
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesCantor Fitzgerald
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!